Global practices of meningococcal vaccine use and impact on invasive disease (Q33850840)

29 July 2017

Global practices of meningococcal vaccine use and impact on invasive disease (English)

1 reference

29 July 2017

meningococcal vaccine

1 reference

1 reference

12

Zulfiqar Bhutta

1 reference

29 July 2017

8

Keith P Klugman

1 reference

29 July 2017

10

Samba Sow

1 reference

29 July 2017

3

Nancy Messonnier

1 reference

29 July 2017

6

Juhani Eskola

1 reference

29 July 2017

Asad Ali

1

1 reference

29 July 2017

Rabab Zehra Jafri

2

1 reference

29 July 2017

Carol Tevi-Benissan

4

1 reference

29 July 2017

David Durrheim

5

1 reference

29 July 2017

Florence Fermon

7

1 reference

29 July 2017

Mary Ramsay

9

1 reference

29 July 2017

Shao Zhujun

11

1 reference

29 July 2017

Jon Abramson

13

1 reference

29 July 2017

1 January 2014

1 reference

Pathogens and Global Health

29 July 2017

1 reference

29 July 2017

108

1 reference

29 July 2017

11-20

1 reference

29 July 2017

1

1 reference

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Costs for households and community perception of meningitis epidemics in burkina faso

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Meningococcal C conjugate vaccine: the experience in England and Wales

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Meningococcal disease: a review on available vaccines and vaccines in development.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

A surveillance network for meningococcal disease in Europe.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Recent trends in meningococcal epidemiology and current vaccine recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Safety of a new conjugate meningococcal C vaccine in infants

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Efficacy of meningococcal vaccine and barriers to vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Controlled tests of anti-meningococcal polysaccharide A vaccine in the African Sahel area (Upper Volta and Mali)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Prevention of secondary cases of meningococcal disease in household contacts by vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa

5 July 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

16th International Pathogenic Neisseria Conference: recent progress towards effective meningococcal disease vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Immunogenicity and tolerability in infants of a New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Australia's century of meningococcal disease: development and the changing ecology of an accidental pathogen.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

[Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4083163

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

29 October 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine in Children Aged 16???24 Months

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F2047773214Y.0000000126

Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision

21 January 2018

1 reference

12 December 2020

Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands

1 reference

12 December 2020

Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom

1 reference

12 December 2020

Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months

1 reference

12 December 2020

Impact of meningococcal C conjugate vaccine use in Australia

1 reference

12 December 2020

Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians

1 reference

12 December 2020

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

1 reference

12 December 2020

Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine

1 reference

12 December 2020

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

12 December 2020

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

12 December 2020

[Pharmacy clinics. Medication of the month. Meningitec]

1 reference

12 December 2020

Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000

1 reference

12 December 2020

Epidemics of meningococcal disease. African meningitis belt, 2001

1 reference

12 December 2020

Effectiveness of meningococcal C conjugate vaccine in teenagers in England

1 reference

12 December 2020

Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010

1 reference

12 December 2020

[Study on safety and immunogenicity of group A/C meningococcal polysaccharide conjugate vaccine]

1 reference

12 December 2020

Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.

1 reference

12 December 2020

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

12 December 2020

Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination

1 reference

12 December 2020

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

1 reference

12 December 2020

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

12 December 2020

Menactra: a meningococcal conjugate vaccine

1 reference

12 December 2020

Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months

1 reference

12 December 2020

10.1179/2047773214Y.0000000126

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference